Luca Bolzani is a senior industrialist and investor in the pharmaceutical sector, with a long-standing track record in building, scaling and internationalising specialised companies.
Trained in organic chemistry, he began his career in research at Zambon before moving into executive leadership. He served as CEO of Micromacinazione and later Sintetica, leading their transformation and international expansion over nearly two decades.
A serial entrepreneur, he has founded and developed multiple companies, with successful exits and continued involvement at board level across Micro Sphere, Schedio and Myia.
He has held key institutional roles within the Swiss pharmaceutical ecosystem, including President and Vice President of Farma Industria Ticino and President of Fondazione Agire, supporting innovation, technology and high-growth enterprises.
Luca combines scientific depth with entrepreneurial execution and strategic vision, bringing a distinctive perspective on industrial growth, innovation and long-term value creation.